Comparison of dopamine and norepinephrine in the treatment of shock.

@article{DeBacker2010ComparisonOD,
  title={Comparison of dopamine and norepinephrine in the treatment of shock.},
  author={Daniel De Backer and Patrick Biston and Jacques Devriendt and Christian Madl and Didier Chochrad and C{\'e}sar Aldecoa and Alexandre Brasseur and Pierre Defrance and P. Gottignies and Jean Louis Vincent},
  journal={The New England journal of medicine},
  year={2010},
  volume={362 9},
  pages={
          779-89
        }
}
BACKGROUND Both dopamine and norepinephrine are recommended as first-line vasopressor agents in the treatment of shock. There is a continuing controversy about whether one agent is superior to the other. METHODS In this multicenter, randomized trial, we assigned patients with shock to receive either dopamine or norepinephrine as first-line vasopressor therapy to restore and maintain blood pressure. When blood pressure could not be maintained with a dose of 20 microg per kilogram of body… 

Figures and Tables from this paper

Angiotensin II for the Treatment of Vasodilatory Shock
TLDR
Angiotensin II effectively increased blood pressure in patients with vasodilatory shock that did not respond to high doses of conventional vasopressors.
Dopamine versus norepinephrine in the treatment of cardiogenic shock
TLDR
A meta-analysis of randomized controlled trials revealed that norepinephrine was associated with a lower 28-day mortality, a lower risk of arrhythmic events, and gastrointestinal reaction, and no matter whether CS is caused by coronary heart disease or not.
Comparison of dopamine and norepinephrine in shock.
  • C. Romero
  • Medicine
    The New England journal of medicine
  • 2010
TLDR
The use of dopamine was associated with a greater number of adverse events in the overall population and an unexpected increase in the rate of death in the subgroup of patients with cardiogenic shock.
Dopamine versus norepinephrine in the treatment of shock.
TLDR
This study compared 28-day mortality in patients with shock who were treated with either dopamine or norepinephrine as initial vasopressor therapy and the authors' secondary outcome measures included mortality beyond 28 days and adverse events associated with each agent.
Effect of Body Weight on Hemodynamic Response in Patients Receiving Fixed-Dose Vasopressin for Septic Shock
TLDR
It is confirmed that vasopressin dose relative toweight was independently associated with change in MAP at 1, 6, and 12 hours, whereas changes in NE dosing were not, and fixed-dose vasopressingin may not be sufficient in obese septic shock patients with a BMI ≥30 kg/m2.
Efficacy and Safety of the Early Addition of Vasopressin to Norepinephrine in Septic Shock
TLDR
Early initiation of vasopressin in patients with septic shock may achieve and maintain goal MAP sooner and resolve organ dysfunction at 72 hours more effectively than later or no initiation.
Comparison of Dopamine and Norepinephrine Use for the Treatment of Hypotension in Out-Of-Hospital Cardiac Arrest Patients with Return of Spontaneous Circulation
TLDR
There was no significant difference in post-ROSC hypotension treatment between dopamine and norepinephrine in 30-day survival and favorable neurologic performance rates.
A Comparison of Initial Monotherapy with Norepinephrine Versus Vasopressin for Resuscitation in Septic Shock
TLDR
The results of this retrospective cohort study evaluated adults who received monotherapy with either norepinephrine or vasopressin as initial vasoactive therapy for the management of septic shock, suggesting noninferiority of vasopressed for the achievement of a mean arterial pressure goal in the first 6 hours of shock onset.
The medical treatment of cardiogenic shock: cardiovascular drugs
TLDR
The first-line therapy remains norepinephrine as it is associated with minimal adverse effects and appears to be associated by the best outcome in network meta-analyses and observational studies suggest an increased risk of death.
Choosing catecholamine therapy for shock
TLDR
Two randomized trials comparing dopamine and norepinephrine as the first vasopressor agent raised major concerns on the use of dopamine, and suggest that nore Alpinephrine may be the first-choice adrenergic agent.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 44 REFERENCES
Vasopressors for shock.
TLDR
The main aim was to assess whether particular vasopressors reduce overall mortality and whether the choice of vasopressor influences outcomes such as length-of-stay in the intensive care unit and health-related quality of life.
Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best?
TLDR
Dopamine and norepinephrine have similar hemodynamic effects, but epinephrine can impair splanchnic circulation in severe septic shock.
Effect of norepinephrine on the outcome of septic shock
TLDR
The results indicate that the use of norepinephrine as part of hemodynamic management may influence outcome favorably in septic shock patients, and contradict the notion that norpinephrine potentiates end-organ hypoperfusion, thereby contributing to increased mortality.
Cardiovascular response to dopamine and early prediction of outcome in septic shock: A prospective multiple-center study*
TLDR
Dopamine sensitivity is associated with decreased mortality rate and early recognition of dopamine resistant septic shock could allow for better screening of patients with an ominous prognosis.
The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis.
TLDR
It is suggested that dopamine may cause an uncompensated increase in splanchnic oxygen requirements in septic patients and Norepinephrine, however, may have a more favorable hemodynamic profile and improve splan Schnic tissue oxygen utilization in sepsis.
Acute Hemodynamic Effects of Dopamine in Patients with Shock
TLDR
Dopamine improves MAP pressure, CO, and UF when shock is due to infection and is superior to Isp which does not increase perfusion pressure to adequate levels and does not improve UF.
Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study*
TLDR
It is suggested that dopamine administration may be associated with increased mortality rates in shock, and there is a need for a prospective study comparing dopamine with other catecholamines in the management of circulatory shock.
Renal, but not systemic, hemodynamic effects of dopamine are influenced by the severity of congestive heart failure*
TLDR
The dose of dopamine producing an optimal improvement of systemic and renal hemodynamics in congestive heart failure is higher than usually reported.
...
1
2
3
4
5
...